Biography

Dr. Yan Peng completed her pediatric residency/chief resident at Beijing Medical University (Peking University Health Science Center) and practiced there as a pediatric nephrologist for two years. After a combined six years of basic science research on kidney disease at Mayo Clinic in Rochester and UT Southwestern Medical Center (UTSW), she went to the University of Pittsburgh Medical Center (UPMC) for pathology residency. After the residency training, she completed two ACGME accredited fellowships in Breast and Gynecologic Pathology and Cytopathology at UPMC and Harvard Medical School, respectively.

Dr. Peng is a surgical pathologist and cytopathologist with extensive expertise in breast and gynecologic pathology and certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology and Cytopathology. She is the pathology representative at the Cancer Committee of the National Cancer Institute (NCI)-designated comprehensive Simmons Cancer Center. She served as Medical Director of Diagnostic Immunohistochemistry Laboratory and Tumor Biomarker Image Analysis Laboratory for about 10 years.

Dr. Peng has participated in multiple NCI breast and gynecologic cancer clinical trials and has served as a clinical investigator for the NCI Cancer Therapy Evaluation Program. She is a co-investigator in multiple NIH RO1 funded research projects on identifying novel therapeutic targets for triple negative breast cancer.

Dr. Peng has published more than 90 peer-reviewed articles. She is an editor of a textbook entitled Practical Breast Pathology (Springer) and an author of multiple book chapters of breast pathology textbooks. She has served as an editorial board member for multiple scientific journals including Human Pathology (Elsevier). She is the section editor of Gynecologic Pathology of Human Pathology Reports (Elsevier).

Dr. Peng has been a member of the University Faculty Promotion and Tenure Committee. She is the chair of Pathology Faculty Mentoring Committee and the facility site director of breast pathology fellowship. She is a past president of North Texas Society of Pathologists. 

Education

Medical School
Beijing Medical University (1986)
Residency
Beijing University Hospital (1989), Pediatrics
Graduate School
Beijing Medical University, China (1991)
Other Post Graduate Training
Beijing Medical University, China (1991)
Fellowship
Mayo Clinic College of Medicine (1995), Physiology
Fellowship
UT Southwestern Medical Center (1999), Molecular Nephrology Research
Residency
University of Pittsburgh Medical Center (2003), Anatomic & Clinical Pathology
Fellowship
University of Pittsburgh Medical Center Magee Womens Hospital (2004), Breast & Gynecologic Pathology
Fellowship
Harvard Medical School/Beth Israel Deaconess Medical Center (2005), Cytopathology

Research Interest

  • Breast Cancer and Gynecologic Cancer Pathology
  • Diagnostic Immunohistochemistry: Theranostic and Genomic Applications
  • Prognostic and predictive tumor biomarkers

Publications

Featured Publications LegendFeatured Publications

Books

Featured Books Legend Featured Books

Honors & Awards

  • Top Doctor (Pathologist)
    Texas Magazine (2022)
  • Session Chair, The Breast Pathology Platform Sessions for the United States and Canadian Academy of Pathology (USCAP) 110th annual meeting
    (2021)
  • Outstanding peer reviewer for Human Pathology (one of leading pathology scientific journals in the US)
    (2018)
  • Member, Abstract Review Board of United States and Canadian Academy of Pathology (Breast Pathology Category)
    (2017-2020)
  • President, International Association of Chinese Pathologists
    (2017-2018)
  • President, UT Southwestern Faculty Senate
    (2017-2018)
  • Finalist for Best Scientific Abstract Award of American Society for Clinical Pathology (senior mentor)
    (2015)
  • Distinguished Young Investigator Award in Medicine
    Beijing, China (1993)
  • Distinguished Scientist Award of Canada China Child Health Foundation
    (1992)
  • Best National Medical Article Award
    China (1991)